Bei C - Search Results

1

Rs2303428 of MSH2 Is Associated with Hepatocellular Carcinoma Prognosis in a Chinese Population.

Zhu X, Wang Z, Qiu X, Wang W, Bei C, Tan C, Qin L, Ren Y, Tan S. Zhu X, et al. Among authors: bei c. DNA Cell Biol. 2018 Jul;37(7):634-641. doi: 10.1089/dna.2018.4224. Epub 2018 Jun 6. DNA Cell Biol. 2018. PMID: 29874113

2

Polymorphisms in microRNA target sites of forkhead box O genes are associated with hepatocellular carcinoma.

Tan C, Liu S, Tan S, Zeng X, Yu H, Li A, Bei C, Qiu X. Tan C, et al. Among authors: bei c. PLoS One. 2015 Mar 4;10(3):e0119210. doi: 10.1371/journal.pone.0119210. eCollection 2015. PLoS One. 2015. PMID: 25739100 Free PMC article.

3

Associations between single nucleotide polymorphisms in RYBP and the prognosis of hepatocellular carcinoma in a Chinese population.

Zhu X, Wang Z, Qiu X, Tan C, Yu H, Bei C, Qin L, Ren Y, Tan S. Zhu X, et al. Among authors: bei c. Carcinogenesis. 2017 May 1;38(5):532-540. doi: 10.1093/carcin/bgx031. Carcinogenesis. 2017. PMID: 28369212

4

Single nucleotide polymorphisms in MLH1 predict poor prognosis of hepatocellular carcinoma in a Chinese population.

Zhu X, Liu W, Qiu X, Wang Z, Tan C, Bei C, Qin L, Ren Y, Tan S. Zhu X, et al. Among authors: bei c. Oncotarget. 2017 Apr 6;8(45):80039-80049. doi: 10.18632/oncotarget.16899. eCollection 2017 Oct 3. Oncotarget. 2017. PMID: 29108386 Free PMC article.

5

Association Between Polymorphisms in CMTM Family Genes and Hepatocellular Carcinoma in Guangxi of China.

Bei C, Tan C, Zhu X, Wang Z, Tan S. Bei C, et al. DNA Cell Biol. 2018 Aug;37(8):691-696. doi: 10.1089/dna.2018.4274. Epub 2018 Jul 10. DNA Cell Biol. 2018. PMID: 29990439

6

Expression and Clinical Significance of CMTM6 in Hepatocellular Carcinoma.

Zhu X, Qi G, Li C, Bei C, Tan C, Zhang Y, Shi W, Zeng W, Kong J, Fu Y, Tan S. Zhu X, et al. Among authors: bei c. DNA Cell Biol. 2019 Feb;38(2):193-197. doi: 10.1089/dna.2018.4513. Epub 2018 Dec 18. DNA Cell Biol. 2019. PMID: 30562063

7

Single Nucleotide Polymorphisms of CBX4 and CBX7 Decrease the Risk of Hepatocellular Carcinoma.

Tan C, Bei C, Zhu X, Zhang Y, Qin L, Tan S. Tan C, et al. Among authors: bei c. Biomed Res Int. 2019 May 9;2019:6436825. doi: 10.1155/2019/6436825. eCollection 2019. Biomed Res Int. 2019. PMID: 31211140 Free PMC article. Clinical Trial.

8

Downregulated Expression of Chromobox Homolog 7 in Hepatocellular Carcinoma.

Zhu X, Qin M, Li C, Zeng W, Bei C, Tan C, Zhang Y, Shi W, Kong J, Fu Y, Tan S. Zhu X, et al. Among authors: bei c. Genet Test Mol Biomarkers. 2019 May;23(5):348-352. doi: 10.1089/gtmb.2018.0293. Epub 2019 Apr 16. Genet Test Mol Biomarkers. 2019. PMID: 30990338

9

Downregulated CMTM2 Poses Potential Clinical Significance in Hepatocellular Carcinoma.

Guo X, Zhang S, Tan S, Bei C, Zhang H, Zhu X, Qiu X. Guo X, et al. Among authors: bei c. DNA Cell Biol. 2020 Apr;39(4):683-689. doi: 10.1089/dna.2019.5237. Epub 2020 Jan 28. DNA Cell Biol. 2020. PMID: 31990600

10

Role of cytokine gene polymorphisms on prognosis in hepatocellular carcinoma after radical surgery resection.

Pan D, Zeng X, Yu H, Yang Y, Bei C, Bai H, Qiu X. Pan D, et al. Among authors: bei c. Gene. 2014 Jul 1;544(1):32-40. doi: 10.1016/j.gene.2014.04.042. Epub 2014 Apr 22. Gene. 2014. PMID: 24768182

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

101 results

Search Page

Filters